NATIONAL HEALTHCARE CORP financials

  1. Home
  2. Financials
  3. NHC
NHC CIK 0001047335

Source: EDGAR filings · Built 2026-06-02T03:39:47Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 148.63M 78.84M 78.33M -26.15M 18.57M 177.22M
EBITDA 173.27M 131.88M 99.49M 72.39M 91.60M 90.17M
Working Capital 208.19M 189.61M 191.76M 156.04M 163.44M 175.53M
Net Debt -5.76M 138.65M -13.69M 67.27M 59.05M 46.92M
Operating Margin 8.46% 6.88% 5.03% 2.94% 4.74% 4.68%
Net Margin 7.91% 7.80% 5.85% 2.07% 12.90% 4.07%
Return on Equity (ROE) 11.23% 10.40% 7.35% 2.57% 15.35% 5.27%
Return on Assets (ROA) 7.86% 6.69% 5.10% 1.76% 9.88% 3.07%
Current Ratio 1.82× 1.81× 1.89× 1.79× 1.62× 1.62×
Debt-to-Equity 0.08× 0.22× 0.10× 0.14× 0.18× 0.24×
Effective Tax Rate 24.52% 25.16% 26.43% 26.64% — —
Cash Conversion Ratio 1.54× 1.05× 1.67× 0.39× 0.45× 4.85×
Accruals Ratio -0.04× -0.00× -0.03× 0.01× 0.05× -0.12×
SBC % of Revenue 0.29% 0.32% 0.24% 0.24% 0.24% 0.24%
CapEx Coverage 5.08× 3.77× 3.38× 0.25× 1.42× 7.81×
Free Cash Flow Per Share $9.50 $5.05 $5.09 $-1.69 $1.20 $11.53

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 17.87× 16.47× 21.29× 41.03× 7.56× 24.42×
P/FCF 14.43× 21.28× 18.14× — 56.40× 5.76×
FCF Yield 6.93% 4.70% 5.51% — 1.77% 17.36%
EV / EBITDA 12.26× 13.65× 14.12× 13.55× 12.11× 11.84×
P/S 1.40× 1.27× 1.24× 0.84× 0.98× 0.99×
P/B 1.99× 1.70× 1.56× 1.05× 1.16× 1.28×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 1.52B 1.31B 1.14B 1.09B 1.07B 1.03B
Operating Income (Loss) 128.35M 89.89M 57.46M 31.90M 50.92M 48.16M
Income Tax Expense (Benefit) 39.83M 34.32M 23.45M 7.25M 10.95M 10.43M
Net Income (Loss) Attributable to Parent 120.02M 101.93M 66.80M 22.45M 138.59M 41.87M
Earnings Per Share, Basic $7.76 $6.62 $4.36 $1.46 $9.03 $2.74
Weighted Average Number of Shares Outstanding, Basic 15.47M 15.39M 15.31M 15.41M 15.35M 15.31M
Earnings Per Share, Diluted $7.67 $6.53 $4.34 $1.45 $8.99 $2.72
Weighted Average Number of Shares Outstanding, Diluted 15.65M 15.60M 15.38M 15.45M 15.42M 15.37M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 92.83M 76.12M 107.08M 58.67M 107.61M 147.09M
Assets, Current 461.82M 424.41M 406.24M 353.93M 426.64M 456.75M
Assets 1.53B 1.52B 1.31B 1.28B 1.40B 1.36B
Long-term Debt 40.00M 137.00M — — — —
Liabilities, Current 253.63M 234.80M 214.48M 197.89M 263.20M 281.23M
Long-term Debt, Excluding Current Maturities 32.50M 129.50M 0 — — —
Liabilities 451.90M 541.27M 400.32M 397.94M 494.94M 563.87M
Stockholders' Equity Attributable to Parent 1.07B 980.16M 908.75M 874.28M 903.00M 795.18M
Common Stock, Shares, Outstanding 15.54M 15.45M 15.35M 15.36M 15.45M 15.37M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 185.08M 107.30M 111.22M 8.74M 62.39M 203.26M
Payments to Acquire Property, Plant, and Equipment 36.45M 27.60M 27.90M 30.20M 39.40M 21.87M
Net Cash Provided by (Used in) Investing Activities -33.86M -236.69M -17.57M -5.98M -65.89M -63.88M
Payments for Repurchase of Common Stock 14.73M 13.50M 2.48M 9.90M 836.00K 53.00K
Net Cash Provided by (Used in) Financing Activities -135.96M 100.34M -42.55M -47.64M -35.26M -41.89M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NHC CIK 0001047335), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

HNI

HNI Corporation

RGEN

REPLIGEN CORP

AUR

Aurora Innovation, Inc.